Capnomed developed the CapnoPen, the nebuliser that sprays chemotherapy as an aerosol into the abdomen during PIPAC, now made by Reger Medizintechnik.
The CapnoPen micropump nebuliser, connected to a standard contrast injector and passed through a laparoscopic port, made pressurised intraperitoneal aerosol chemotherapy reproducible after the technique was introduced in Germany in 2011. Capnomed's device line was taken over by Reger Medizintechnik, which continues to supply the CE-marked nebuliser used in most PIPAC programmes and trials.
Shares HIPEC perfusion pumps and PIPAC nebulisers, HIPEC / PIPAC (intraperitoneal chemotherapy), Ovarian cancer, Colorectal cancer and the tag machines-wave2.
Shares HIPEC perfusion pumps and PIPAC nebulisers, Colorectal cancer and the tag machines-wave2.
Shares HIPEC perfusion pumps and PIPAC nebulisers and the tag machines-wave2.
Shares Gastric & gastro-oesophageal junction cancer, Colorectal cancer and the tag machines-wave2.
Shares Gastric & gastro-oesophageal junction cancer, Pancreatic ductal adenocarcinoma, Colorectal cancer and the tag machines-wave2.
Shares Ovarian cancer, Colorectal cancer and the tag machines-wave2.
Shares Pancreatic ductal adenocarcinoma and the tag machines-wave2.
Shares Pancreatic ductal adenocarcinoma and the tag machines-wave2.